Healthcare
Japan's J-Star sees 3x return on Apo Plus Station
Mid-market Japanese GP J-Star has sold its majority stake in the pharma-focused contract sales company Apo Plus Station (APS) to Qol, a Tokyo-based pharmaceutical firm.
Hong Kong PE firm backs heart failure treatment
Hong Kong-based Themes Investment Partners has led a $20 million equity financing round in LoneStar Heart, a California-based biomedical company developing new therapies for patients with heart failure.
Actis supports Sri Lanka hospital consolidation
For Asiri Hospital Holdings (AHH) in Sri Lanka, read India’s Sterling Hospitals in India. Actis, which has acquired a $32 million equity stake in the Sri Lankan healthcare operator, found itself looking at a similar market dynamic when it first invested...
Actis invests in Sri Lankan hospital chain
Emerging markets-focused private equity firm Actis has invested $32 million for approximately 30% of Asiri Hospital Holdings (AHH), Sri Lanka’s largest private hospital group. The company operates three facilities in Colombo and two in Matara, with a...
Navis invests in Vietnam pharma firm
Navis Capital Partners has invested into OPV Pharmaceutical, a major Vietnamese branded generic pharmaceutical manufacturer.
NVP invests $22m in Indian medical diagnostics firm
Norwest Venture Partners (NVP) has bought a 10% stake in India’s Thyrocare Technologies from the medical diagnostics services provider’s promoters for INR1.2 billion ($22 million).
Wellington Partners leads $3.4m Series A for AyoxxA Biosystems
Wellington Partners Venture Capital has led a EUR2.6 million ($3.4 million) Series A round of financing in AyoxxA Biosystems, a biotech firm based in Singapore and Germany. The capital will provide AyoxxA with the resources to scale-up production of bead-based...
IndoUS Ventures leads Vyome Biosciences Series A round Partners
Vyome Biosciences, a Delhi-based biopharmaceutical company that focuses on dermatology, has raised $3.3 million in Series A financing. The round was led by IndoUS Venture Partners, with Aarin Capital and existing investor Navam Capital also participating....
PE-backed Max India sells polypropylene film unit for $97m
Max India, which is backed by Goldman Sachs, International Financial Corporation (IFC) and Temasek Holdings, has sold its biaxially oriented polypropylene (BOPP) film division to Germany's Treofan for INR5.4 billion ($97 million). The divestment allows...
CITIC PE backs $331m take-private bid for China's 3SBio
CITIC Private Equity is supporting a $331 million management buyout offer for NASDAQ-listed Chinese pharmaceuticals company 3SBio. It is the latest in a string of attempted take-private deals for US-traded Chinese firms that for a variety of reasons are...
RRJ Capital invests $50m in Chinese biotech firm - source
RRJ Capital is said to have injected $50 million in Chinese biotech company Triplex Biosciences, taking an 11-19% stake in the company.
NVP backs Indian healthcare clinics with $4.5m
Norwest Venture Partners (NVP) has invested INR250 million ($4.5 million) in NationWide Primary Healthcare Services, an Indian retail chain of primary care clinics.
Olympus-backed DM Healthcare outlines India spending plans
Olympus-backed DM Healthcare, a Dubai-based healthcare services provider which gets a majority of its business in the Middle East, will invest INR15 billion ($270 million) in India. The company hopes this will help boost overall revenues by 40% to INR23...
IFC invests $47m in China's Fosun Pharma
International Finance Corporation (IFC), the private investment arm of the World Bank, has agreed to provide RMB300 million ($47 million) in funding to Fosun Pharma, one of China’s leading drug companies. The investment will help Fosun scale up the production...
India Value Advisors to invest $179m in Manipal Hospitals
India Value Advisors (IVFA) will commit about INR10 billion ($179 million) to Manipal Hospitals over a three-year period, enabling the healthcare provider to more than double its hospital bed capacity. Part of this increase will come through acquisitions....
Buyout firms progress in Indonesia healthcare auction - report
The Blackstone Group, Bain Capital, KKR and Abraaj Capital are said to have made it through to the second round of the auction process for a 20% stake in Siloam, Indonesia’s biggest private hospital firm. The deal is expected to be worth up to $300 million....
Archer Growth prepares for Cura Day exit – report
Archer Capital Growth is reportedly preparing to exit Cura Day Hospitals Group. The Australian GP helped found the company in 2008, having teamed up with a group of doctors and medical specialists who manage and work at its nationwide network of day hospitals....
Carlyle sees rare scale opportunity in Meinian Onehealth
The Carlyle Group was drawn to China’s Meinian Onehealth because it represented one of few true nationwide healthcare services providers in a fragmented market.
Actis invests in Sri Lanka's Asiri Central Hospitals
Actis has purchased a 10.8% stake in Sri Lanka’s Asiri Central Hospitals for LKR604 million ($4.5 million). The emerging markets-focused private equity firm acquired 2.4 million shares in the Colombo-listed company from Softlogic Holdings, Commercial...
Peepul Capital makes two investments in Chennai
Peepul Capital, an India-focused private equity firm, has invested $15-25 million each in two Chennai-based companies - Consul Consolidated, a power solution company, and Cura Healthcare, a radiology equipment maker. Both investments were channeled from...
Carlyle picks up 14% of Meinian Onehealth
Global private equity major The Carlyle Group has acquired a 13.5% stake in Meinian Onehealth Healthcare, the largest private provider of preventive healthcare check-up services in China.
Goldman, NEA invest in India's Nova Medical Centers
Goldman Sachs and New Enterprise Associates (NEA) have invested INR 3 billion ($54 million) in Nova Medical Centers, an Indian surgical care and fertility clinics company. The investments will be used to expand the company's specialty surgery and fertility...
Taiwan's PharmaEngine signs Asia deal with VC-backed Nanobiotix
Taiwanese biopharmaceutical company PharmaEngine has agreed to form a strategic partnership with VC-backed Nanobiotix, to hasten the development of one of the French nanomedicine firm’s products.
China biotech: Elusive innovation?
PE and VC investors want to leverage China’s rapidly growing biotech industry, but few firms have a proven ability to commercialize their innovations in drug development. Change will come, gradually.